Xenon Pharmaceuticals (XENE)
(Real Time Quote from BATS)
$40.60 USD
+0.06 (0.15%)
Updated May 13, 2024 04:00 PM ET
After-Market: $40.50 -0.10 (-0.25%) 4:18 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
XENE 40.60 +0.06(0.15%)
Will XENE be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for XENE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for XENE
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock
XENE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus
Here's Why You Should Add Xenon (XENE) to Your Portfolio Now
Wall Street Analysts Think Xenon Pharmaceuticals (XENE) Could Surge 25.76%: Read This Before Placing a Bet
Other News for XENE
Buy Rating Affirmed: Xenon’s Strategic Advancements in MDD Development and Diversified Pipeline
Xenon Pharmaceuticals Inc (XENE) Reports Increased Losses in Q1 2024, Despite Advancements in ...
Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Xenon (XENE) and BioLife Solutions (BLFS)
Xenon Pharmaceuticals price target lowered by $1 at Wedbush, here's why
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Catalyst Pharma (CPRX), Xenon (XENE) and Intellia Therapeutics (NTLA)